A NEW CANDIDATE FOR THE L-NUCLEOSIDES RESERVOIR MALINA JASAMAI Department of Pharmacy, FSKB, UKM.
Aims and Objectives
Overview Nucleoside structure - Mechanism of action Target compounds - Comparison between thio and oxo and rationale for thio synthesis - L -thionucleosides Synthetic methodology Antiviral assay
Introduction Structure of nucleotide and nucleoside
Nucleoside analogues in clinical use
Mechanism of Action
Target Compounds
Thio vs Oxo Rationale of isostere substitution: increased stability against nucleoside phosphorylase reduced toxicity in vivo
Eureka!
Biological Evaluation Cell typesVirusesPeriod of incubation HEL cells HSV-1, HSV-2, Vaccinia virus, VZV and HSV TK - ACV days HeLa cells VSV, Coxakie B1 virus and RSV1-2 days Vero cells Simbis virus and Coxakie B1 virus Punta Toro virus, Reo virus and Parainfluenza virus 1-2 days 3-4 days CCRF-CEM cells HIV-1 and HIV-23-4 days MT-4 cells HIV-2 and HIV-23-4 days
Million of Thanks! Malaysian Government for Phd funding Dr Claire Simons for her supervision and assistance Prof Jan Balzarini and staff at Rega Institute My colleagues in Lab 2.22 and everyone in Medicinal Chemistry discipline